Resmed (RSMDF) Assets (2010 - 2026)

Resmed (RSMDF) has reported Assets for 17 consecutive years, with $9.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets rose 9.68% year-over-year to $9.0 billion; the trailing twelve-month figure through Jun 2026 stood at $9.0 billion (up 9.68% YoY), and the FY2026 full-year result was $9.0 billion, up 9.68% from the prior year.
• Assets grew to $9.0 billion in Q2 2026 per RSMDF's latest filing, from $8.8 billion in the prior quarter.
• Across five years, Assets topped out at $9.0 billion in Q2 2026 and bottomed at $4.9 billion in Q1 2022.
• Historically, Assets has averaged $7.1 billion across 5 years, with a median of $6.9 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Assets jumped 41.0% in 2022, then advanced 1.5% in 2024.
• Over 5 years, Assets stood at $6.7 billion in 2022, then climbed by 3.43% to $6.9 billion in 2023, then climbed by 3.42% to $7.1 billion in 2024, then advanced by 19.07% to $8.5 billion in 2025, then grew by 5.44% to $9.0 billion in 2026.
• According to Business Quant data, Assets over the past three periods registered $9.0 billion, $8.8 billion, and $8.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.